Overview

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Status:
NOT_YET_RECRUITING
Trial end date:
2028-12-15
Target enrollment:
Participant gender:
Summary
This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
Phase:
PHASE2
Details
Lead Sponsor:
Jazz Pharmaceuticals
Treatments:
ONC206